Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy

被引：10

作者：

Guex, AC

Radziwill, AJ

Bucher, HC ^{[1
]}

机构：

[1] Univ Basel, Kantonsspital, Med Poliklin, CH-4031 Basel, Switzerland

[2] Univ Basel, Kantonsspital, Neurol Klin, CH-4031 Basel, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2000年 / 30卷 / 03期

关键词：

D O I：

10.1086/313733

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：602 / 603

页数：2

共 5 条

[1] Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients [J].

Bucher, HC ;

Griffith, L ;

Guyatt, GH ;

Opravil, M .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (02) :104-114

[2] Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy [J].

Furrer, H ;

Egger, M ;

Opravil, M ;

Bernasconi, E ;

Hirschel, B ;

Battegay, M ;

Telenti, A ;

Vernazza, PL ;

Rickenbach, M ;

Flepp, M ;

Malinverni, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1301-1306

[3] Pyrimethamine-clindamycin vs pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS [J].

Katlama, C ;

DeWit, S ;

ODoherty, E ;

VanGlabeke, M ;

Clumeck, N ;

Payen, MC ;

Mathiesen, L ;

Nielsen, JO ;

Pedersen, C ;

Dupont, B ;

Pialoux, G ;

Janbon, F ;

Reynes, J ;

Gallais, H ;

Mars, ME ;

Jeantils, V ;

Schneider, MC ;

Averous, V ;

Decazes, JM ;

DocoLecompte, T ;

Modai, J ;

Molina, JM ;

Blanc, A ;

Delfraissy, JF ;

Guillevin, L ;

Jarrousse, B ;

Sehouane, R ;

Trogoff, B ;

Armengaud, M ;

Marchou, B ;

Meurisse, JJ ;

Gentilini, M ;

Guichard, A ;

Rogeaux, O ;

Livrozet, JM ;

Touraine, JL ;

Sereni, D ;

Rousseau, F ;

Pesce, A ;

Coulaud, JP ;

Detruchis, P ;

Fegueux, S ;

Maslo, C ;

Matheron, S ;

Raffi, F ;

Bassetti, D ;

Canessa, A ;

DelBono, V ;

DeLeo, P ;

Terragna, A .

CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) :268-275

[4]

*USPHS IDSA PREV O, 1997, MMWR-MORBID MORTAL W, V46, P1

[5] Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection [J].

Weverling, GJ ;

Mocroft, A ;

Ledergerber, B ;

Kirk, O ;

González-Lahoz, J ;

Monforte, AD ;

Proenca, R ;

Phillips, AN ;

Lundgren, JD ;

Reiss, P .

LANCET, 1999, 353 (9161) :1293-1298

← 1 →